يعرض 91 - 100 نتائج من 145 نتيجة بحث عن '"(1"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 91
    دورية أكاديمية
  2. 92
    دورية أكاديمية
  3. 93
    دورية أكاديمية

    المصدر: Harrison , C , Kiladjian , J-J , Al-Ali , H K , Gisslinger , H , Waltzman , R , Stalbovskaya , V , McQuitty , M , Hunter , D S , Levy , R , Knoops , L , Cervantes , F , Vannucchi , A M , Barbui , T & Barosi , G 2012 , ' JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis ' , New England Journal of Medicine , vol. 366 , no. 9 , pp. 787-98 . https://doi.org/10.1056/NEJMoa1110556Test

  4. 94
    دورية أكاديمية

    المصدر: Harrison , C , Kiladjian , J-J , Al-Ali , H K , Gisslinger , H , Waltzman , R , Stalbovskaya , V , McQuitty , M , Hunter , D S , Levy , R , Knoops , L , Cervantes , F , Vannucchi , A M , Barbui , T & Barosi , G 2012 , ' JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis ' , New England Journal of Medicine , vol. 366 , no. 9 , pp. 787-98 . https://doi.org/10.1056/NEJMoa1110556Test

  5. 95
    دورية أكاديمية

    المصدر: Nin , J W , Jorsal , A , Ferreira , I , Schalkwijk , C G , Prins , M H , Parving , H-H , Tarnow , L , Rossing , P & Stehouwer , C D 2011 , ' Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes : a 12-year follow-up study ' , Diabetes Care , vol. 34 , no. 2 , pp. 442-7 . https://doi.org/10.2337/dc10-1087Test

  6. 96
    دورية أكاديمية
  7. 97
    دورية أكاديمية
  8. 98
    دورية أكاديمية
  9. 99
    دورية أكاديمية

    المصدر: Nin , J W M , Jorsal , A , Ferreira , I , Schalkwijk , C G , Prins , M H , Parving , H-H , Tarnow , L , Rossing , P & Stehouwer , C D A 2010 , ' Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes : a 12-year follow-up study ' , Diabetes , vol. 59 , no. 8 , pp. 2027-32 . https://doi.org/10.2337/db09-1509Test

  10. 100
    دورية أكاديمية

    المصدر: Lajer , M S , Jorsal , A , Tarnow , L , Parving , H-H & Rossing , P 2010 , ' Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy ' , Diabetes Care , vol. 33 , no. 7 , pp. 1567-72 . https://doi.org/10.2337/dc09-2174Test